RAS and connective tissue in the heart

Area of Science:

• Cardiovascular Science
• Molecular Cardiology
• Tissue Engineering

Background:

• The peptide angiotensin II (AngII) exerts endocrine effects on the cardiovascular system.
• AngII is also produced locally within the heart, acting via autocrine and paracrine mechanisms on resident cells through the AT(1) receptor.
• The cardiac renin-angiotensin system (RAS) plays a role in tissue remodeling.

Purpose of the Study:

• To review the cardiac renin-angiotensin system.
• To explore the role of the cardiac RAS in connective tissue turnover.
• To examine the impact of the cardiac RAS on heart valve leaflets and fibrous tissue formation after injury.

Main Methods:

• Literature review of studies on the cardiac renin-angiotensin system.
• Analysis of research on AngII signaling pathways in cardiac cells.
• Examination of studies investigating connective tissue remodeling in the heart.

Main Results:

• Local cardiac AngII production influences resident cells through AT(1) receptor signaling.
• The cardiac RAS is implicated in the turnover of connective tissue within heart valve leaflets.
• Fibrous tissue formation at injury sites, like myocardial infarction, involves the cardiac RAS.

Conclusions:

• The cardiac renin-angiotensin system has significant autocrine and paracrine roles within the heart.
• The cardiac RAS is a key regulator of connective tissue remodeling in heart valves and following cardiac injury.
• Understanding the cardiac RAS is crucial for addressing cardiovascular diseases involving tissue damage and fibrosis.